RecruitingNot ApplicableNCT07285564

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer


Sponsor

Centre Henri Becquerel

Enrollment

10 participants

Start Date

Nov 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is evaluating whether a small, specialized PET/CT scanner (micro-PET-CT) can help surgeons confirm in real time that all cancer has been removed during operations for head and neck cancer. **You may be eligible if...** - You are 18 or older with a malignant tumor in the mouth, throat, voice box, sinuses, or salivary glands - Your cancer has not spread to distant organs (M0) - You are scheduled for surgery and your cancer is considered operable - You are covered under a social security plan (French social security required) **You may NOT be eligible if...** - You have severe liver failure (Child-Pugh C) - You are under legal guardianship or protection - You are pregnant or breastfeeding - You have an allergy to the imaging tracer (18F-FDG) - You have uncontrolled diabetes - You have moderate to severe kidney disease - You are unable to understand or comply with study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEmicro PET/CT

PET/T of the speciment after surgery


Locations(1)

Centre Henri Becquerel

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07285564


Related Trials